Latest Sales Growth News

Terragen Holdings reports a strong quarter with an 87% increase in sales of its ruminant probiotic and advances key livestock and crop trials, positioning itself for expanded market access.

Range International Limited has reported its strongest quarterly sales and production figures yet in Indonesia, while strategically pivoting towards a pallet rental model to secure more stable revenue streams.

AnteoTech has marked significant progress in battery and life sciences sectors, highlighted by a major capital raise and strategic US partnership. The company is poised to convert promising trials into sales amid expanding market opportunities.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Carma Limited has reported a surge in vehicle sales and revenue in its latest quarterly report, alongside a successful $100 million IPO that strengthens its growth trajectory.

TALi Digital has completed the integration of its YCDI! acquisition, upgraded its digital learning platform, and launched new courses targeting educators and neurodivergent learners, positioning itself for growth in 2026.

Little Green Pharma reports record quarterly revenue and announces a transformative merger with Cannatrek, creating a leading vertically integrated medicinal cannabis group with strong European growth prospects.

Mustera Property Group reports strong sales momentum with $15.05 million contracted at its Verse on McCabe development, alongside a $3 million settlement at Forbes Residences, setting the stage for construction to begin in Q2 2026.

Eneco Refresh Limited reported a 4% increase in total revenue for Q2 FY26, driven by gains in its Refresh Waters and Plastics segments despite some regional setbacks. The company also maintained positive operating cash flow while managing rising supply chain costs.

Jatcorp Limited reported a striking 165% revenue increase in Q2 FY26, driven by strong demand in Australia, Hong Kong, and China. The company also secured $4.2 million through an entitlement offer to support its growth ambitions across Southeast Asia.

Starpharma reports strong progress in strategic collaborations and internal drug development, alongside a 70% surge in Viraleze™ online sales and a solid $18.2 million cash position.

Urbanise.com Limited reported a 22% revenue increase in Q2 FY2026, driven by its strategic partnership with National Australia Bank and ongoing development of its Data and Payments Integration Services platform. Despite short-term cash outflows, the company targets positive operating cash flow by FY2027.